SLC2A1 and ovarian carcinoma: Resveratrol (RSV) has no effect on GLUT1 mRNA and protein expressions but disturbs intracellular GLUT1 trafficking to the plasma membrane by suppressing AKT/mTOR activation, which ultimately impairs glucose uptake and induces apoptosis in ovarian cancer cells (154).